IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma

Yang Ying; Wang Jin; Xu Shihai; Lv Wen; Shi Fei; Shan Aijun

doi:10.1515/tnsci-2021-0002

Translational Neuroscience (Jan 2021)

IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma

Yang Ying,
Wang Jin,
Xu Shihai,
Lv Wen,
Shi Fei,
Shan Aijun

Affiliations

Yang Ying: Department of Pediatrics, Futian Women and Children Health Institute, Shenzhen 518045, China
Wang Jin
Xu Shihai
Lv Wen: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China
Shi Fei: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China
Shan Aijun: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China

DOI: https://doi.org/10.1515/tnsci-2021-0002
Journal volume & issue: Vol. 12, no. 1
pp. 009 – 019

Abstract

Read online

In cancer, kappa B-interacting protein (IKBIP) has rarely been reported. This study aimed at investigating its expression pattern and biological function in brain glioma at the transcriptional level.

Published in Translational Neuroscience

ISSN: 2081-6936 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.degruyter.com/view/j/tnsci

About the journal

Abstract

Keywords